SEQUENT SCIENTIFIC
Back to Balance Sheet
|
SEQUENT SCIENTIFIC Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹627 Cr | ₹559 Cr | ₹537 Cr | ₹513 Cr | ₹515 Cr |
What is the latest Total Current Liabilities ratio of SEQUENT SCIENTIFIC ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹627 Cr |
Mar2023 | ₹559 Cr |
Mar2022 | ₹537 Cr |
Mar2021 | ₹513 Cr |
Mar2020 | ₹515 Cr |
How is Total Current Liabilities of SEQUENT SCIENTIFIC Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹627 Cr | 12.21 | |
Mar2023 | ₹559 Cr | 3.98 | |
Mar2022 | ₹537 Cr | 4.72 | |
Mar2021 | ₹513 Cr | -0.34 | |
Mar2020 | ₹515 Cr | - |
Compare Total Current Liabilities of peers of SEQUENT SCIENTIFIC
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SEQUENT SCIENTIFIC | ₹4,467.9 Cr | -3.8% | -7.1% | 54.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹433,920.0 Cr | -0.1% | 1.7% | 45.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹155,160.0 Cr | -0.1% | -2.2% | 56.9% | Stock Analytics | |
CIPLA | ₹118,917.0 Cr | 1.7% | 0.5% | 23.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,017.0 Cr | 5.7% | 12.4% | 18.5% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,997.1 Cr | -1.4% | 3.1% | 44.8% | Stock Analytics |
SEQUENT SCIENTIFIC Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SEQUENT SCIENTIFIC | -3.8% |
-7.1% |
54.6% |
SENSEX | -5% |
0.6% |
9.2% |
You may also like the below Video Courses